Difesa Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-9,250
| Closed | -$802K | – | 6 |
|
|
2023
Q2 | $802K | Sell |
9,250
-2,200
| -19% | -$191K | 2.11% | 14 |
|
|
2023
Q1 | $1.11M | Buy |
11,450
+450
| +4% | +$43.8K | 0.73% | 43 |
|
|
2022
Q4 | $1.14M | Buy |
11,000
+8,000
| +267% | +$828K | 0.88% | 52 |
|
|
2022
Q3 | $254K | Buy |
3,000
+250
| +9% | +$21.2K | 0.13% | 89 |
|
|
2022
Q2 | $228K | Buy |
+2,750
| New | +$228K | 0.13% | 94 |
|